valsartan + telmisartan + olmesartan

The query asks about a combination of valsartan, telmisartan, and olmesartan as if it were a single medication. Based on available information, these are three distinct angiotensin II receptor blockers (ARBs) that are **not typically formulated or used together** as a single combination drug. Each is an individual medication used primarily to treat hypertension (high blood pressure) by blocking the effects of angiotensin II, leading to vasodilation and reduced blood pressure. Combining multiple drugs from the same class with identical mechanisms of action (like these three ARBs) is generally not recommended due to the lack of evidence of increased benefit and a higher risk of adverse effects, such as hypotension, hyperkalemia, and kidney problems. The information provided explicitly states that these medications should not be used together as they affect the same system (renin-angiotensin-aldosterone system) and could cause adverse effects. Instead, each of these ARBs may be found in legitimate combination products with drugs from *different* classes, such as calcium channel blockers (e.g., amlodipine) or diuretics (e.g., hydrochlorothiazide), to provide additive effects for blood pressure control. Therefore, "valsartan + telmisartan + olmesartan" refers to an incorrect or non-standard combination of three individual pharmaceutical drugs.